DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Wednesday reported a loss of $3.9 million in its fourth quarter.
The Dublin, Ohio-based company said it had a loss of 2 cents per share.
The biopharmaceutical posted revenue of $3.4 million in the period.
For the year, the company reported that its loss narrowed to $14.3 million, or 9 cents per share. Revenue was reported as $22 million.
In the final minutes of trading on Wednesday, the company's shares hit 57 cents. A year ago, they were trading at 93 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NAVB at https://www.zacks.com/ap/NAVB
Keywords: Navidea Biopharma, Earnings Report